Antiretroviral drug resistance mutations among treated and treatment-naive patients in Pakistan: Diversity of the HIV type 1 pol gene in Pakistan

AIDS Research and Human Retroviruses

Volumn 27, Issue 12, 2011, Pages 1277-1282

  Shah, Sharaf ^a,b   Xing, Hui ^c   Altaf, Arshad ^b,d   Chen, Bing ^d   Liao, Lingjie ^e   Jia, Yujiang ^d,e,f   Vermund, Sten H ^d,e   Shao, Yiming ^d  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^b Bridge Consultants Foundation   (Pakistan)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d VANDERBILT UNIVERSITY   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f Department of Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; POL PROTEIN; PROTEINASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BLOOD ANALYSIS; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; INTRAVENOUS DRUG ABUSE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PHYLOGENY; PHYSICIAN; POINT MUTATION; PRIORITY JOURNAL; PRISONER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEXUAL BEHAVIOR; SEXUAL DEVIATION; SPOUSE; STRUCTURAL GENE; VIRUS GENE;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, VIRAL; FEMALE; GENES, POL; GENETIC VARIATION; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION; PAKISTAN;

EID: 82455198742     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0324     Document Type: Article

References (19)

1. Vella S: Future treatment perspectives. J Acquir Immune Defic Syndr 2003;34(Suppl 1):S95-100. (Pubitemid 37158640)
2. Paredes R and Clotet B: Clinical management of HIV-1 resistance. Antiviral Res 2010;85(1):245-265. Epub Oct. 4, 2009.
3. Shekelle P, Maglione M, Geotz MB, Wagner G, Wang Z, Hilton L, Carter J, Chen S, Tringle C, Mojica W, and Newberry S: Antiretroviral (ARV) drug resistance in the developing world. Evid Rep Technol Assess (Full Rep) 2007; (156):1-74.
4. Altaf A, Abbas S, and Zaheer HA: Men who have sex with men: New emerging threat of HIV/AIDS spread in Pakistan. J Pak Med Assoc 2008;58(8):419-420.
5. Altaf A, Saleem N, Abbas S, and Muzaffar R: High prevalence of HIV infection among injection drug users (IDUs) in Hyderabad and Sukkur, Pakistan. J Pak Med Assoc 2009;59(3):136-140.
6. Shah SA, Altaf A, Khanani R, and Vermund SH: Antiretroviral drugs obtained without prescription for treatment of HIV/AIDS in Pakistan: Patient mismanagement as a serious threat for drug resistance. J Coll Physicians Surg Pak 2005;15(6):378. (Pubitemid 40959806)
7. Taylor BS, Sobieszczyk ME, McCutchan FE, and Hammer SM: The challenge of HIV-1 subtype diversity. N Engl J Med 2008;358(15):1590-1602.
8. Youngpairoj AS, Masciotra S, Garrido C, Zahonero N, de Mendoza C, and Garcia-Lerma JG: HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 degrees C. J Antimicrob Chemother 2008,61:1217-1220. (Pubitemid 351753584)
9. Liao L, Xing H, Li X, Ruan Y, Zhang Y, Qin G, and Shao Y: Genotypic analysis of the protease and reverse transcriptase of HIV type 1 isolates from recently infected injecting drug users in western China. AIDS Res Hum Retroviruses 2007;23:1062-1065. (Pubitemid 47492349)
10. Khan S, Rai MA, Khanani MR, Khan MN, and Ali SH: HIV-1 subtype A infection in a community of intravenous drug users in Pakistan. BMC Infect Dis 2006;6:164.
11. Nerukar V, Shah SA, Memon A, Minh T, Nguyen F, Vermund S, and Yanagara R: Multiclade HIV-1 infection in Pakistan. Abstract presented in the US-Japan Cooperative Medical Science Program. 13th Joint Meeting of AIDS Panel, Japan, 2003.
12. Surveillance Data of three years (2002-4), Sindh AIDS Control Program, Government of Sindh, 2004.
13. Shah SA, Altaf A, Mujeeb SA, and Memon A: An outbreak of HIV infection among injection drug users in a small town in Pakistan: Potential for national implications. Int J STD AIDS 2004;15(3):209. (Pubitemid 38392118)
14. Shah SA, Khan OA, Kristensen S, and Vermund SH: HIVinfected workers deported from the Gulf States: Impact on Southern Pakistan. Int J STD AIDS 1999;10(12):812-814.
15. Sanders-Buell E, Saad MD, Abed AM, Bose M, Todd CS, Strathdee SA, Botros BA, Safi N, Earhart KC, Scott PT, Michael N, and McCutchan FE: A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35-AD. AIDS Res Hum Retroviruses 2007;23(6):834-839. (Pubitemid 47047924)
16. Bhanja P, Sengupta S, Singh NY, Sarkar K, Bhattacharya SK, and Chakrabarti S: Determination of gag and env subtypes of HIV-1 detected among injecting drug users (IDUs) in Manipur, India: Evidence for intersubtype recombination. Virus Res 2005;114(1-2):149-153. Epub July 28, 2005.
17. Chakrabarti S, Panda S, Chatterjee A, Sarkar S, Manna B, Singh NB, Naik TN, Detels R, and Bhattacharya SK: HIV- 1 subtypes in injecting drug users and their non-injecting wives in Manipur, India. Indian J Med Res 2000;111: 189-194. (Pubitemid 30657557)
18. Sen S, Tripathy SP, Patil AA, Chimanpure VM, and Paranjape RS: High prevalence of human immunodeficiency virus type 1 drug resistance mutations in antiretroviral treatment-experienced patients from Pune, India. AIDS Res Hum Retroviruses 2007;23(10):1303-1308. (Pubitemid 350014773)
19. Sen S, Tripathy SP, Chimanpure VM, Patil AA, Bagul RD, and Paranjape RS: Human immunodeficiency virus type 1 drug resistance mutations in peripheral blood mononuclear cell proviral DNA among antiretroviral treatment-naive and treatment-experienced patients from Pune, India. AIDS Res Hum Retroviruses 2007;23(4):489-497. (Pubitemid 46700880)